ATE526396T1 - Verfahren zur expansion von nabelschnurblutzellen - Google Patents

Verfahren zur expansion von nabelschnurblutzellen

Info

Publication number
ATE526396T1
ATE526396T1 AT05738833T AT05738833T ATE526396T1 AT E526396 T1 ATE526396 T1 AT E526396T1 AT 05738833 T AT05738833 T AT 05738833T AT 05738833 T AT05738833 T AT 05738833T AT E526396 T1 ATE526396 T1 AT E526396T1
Authority
AT
Austria
Prior art keywords
cells
expansion
cultures
hyperthermia
days
Prior art date
Application number
AT05738833T
Other languages
English (en)
Inventor
Nicolas Dupuis
Chantal Proulx
Original Assignee
Hema Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hema Quebec filed Critical Hema Quebec
Application granted granted Critical
Publication of ATE526396T1 publication Critical patent/ATE526396T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05738833T 2004-04-23 2005-04-25 Verfahren zur expansion von nabelschnurblutzellen ATE526396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56458104P 2004-04-23 2004-04-23
PCT/CA2005/000628 WO2005103234A1 (en) 2004-04-23 2005-04-25 A new method of expanding cord blood cells

Publications (1)

Publication Number Publication Date
ATE526396T1 true ATE526396T1 (de) 2011-10-15

Family

ID=35196968

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05738833T ATE526396T1 (de) 2004-04-23 2005-04-25 Verfahren zur expansion von nabelschnurblutzellen

Country Status (5)

Country Link
US (1) US7452662B2 (de)
EP (1) EP1743024B1 (de)
AT (1) ATE526396T1 (de)
CA (1) CA2562760C (de)
WO (1) WO2005103234A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110293574A1 (en) * 2008-09-26 2011-12-01 Chute John P Hematopoietic stem cell growth factor
WO2012061146A1 (en) 2010-10-25 2012-05-10 The Children's Hospital Of Philadelphia Compositions and methods for the generation of platelets and methods of use thereof
US10828329B2 (en) 2015-06-05 2020-11-10 Hema-Quebec Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof
EP3484496B1 (de) * 2016-07-14 2023-12-27 University of Southern California Verfahren und zusammensetzung zur herstellung und verwendung von immunzellen und stammzellen für zellbasierte therapien
US11136543B1 (en) 2020-02-11 2021-10-05 Edward R. Flynn Magnetic cell incubation device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722914A (en) * 1984-05-30 1988-02-02 Motorola Inc. Method of making a high density IC module assembly
US4630096A (en) * 1984-05-30 1986-12-16 Motorola, Inc. High density IC module assembly
US4783695A (en) * 1986-09-26 1988-11-08 General Electric Company Multichip integrated circuit packaging configuration and method
US4890156A (en) * 1987-03-13 1989-12-26 Motorola Inc. Multichip IC module having coplanar dice and substrate
US4792533A (en) * 1987-03-13 1988-12-20 Motorola Inc. Coplanar die to substrate bond method
US5161093A (en) * 1990-07-02 1992-11-03 General Electric Company Multiple lamination high density interconnect process and structure employing a variable crosslinking adhesive
EP0547807A3 (en) * 1991-12-16 1993-09-22 General Electric Company Packaged electronic system
US5592025A (en) * 1992-08-06 1997-01-07 Motorola, Inc. Pad array semiconductor device
US5353498A (en) * 1993-02-08 1994-10-11 General Electric Company Method for fabricating an integrated circuit module
US5841193A (en) * 1996-05-20 1998-11-24 Epic Technologies, Inc. Single chip modules, repairable multichip modules, and methods of fabrication thereof
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US5989935A (en) * 1996-11-19 1999-11-23 Texas Instruments Incorporated Column grid array for semiconductor packaging and method
WO2000028813A1 (en) * 1998-11-19 2000-05-25 St. Elizabeth's Medical Center Treatment of myelogenous leukemia
US20020064931A1 (en) * 2000-07-03 2002-05-30 E. C. Ong Method and apparatus for applying a protective over-coating to a ball-grid-array (BGA) structure
WO2002100898A2 (en) 2001-06-11 2002-12-19 Kirin Beer Kabushiki Kaisha Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same

Also Published As

Publication number Publication date
EP1743024B1 (de) 2011-09-28
US20050266557A1 (en) 2005-12-01
CA2562760C (en) 2009-07-14
EP1743024A4 (de) 2008-03-26
WO2005103234A1 (en) 2005-11-03
EP1743024A1 (de) 2007-01-17
CA2562760A1 (en) 2005-11-03
US7452662B2 (en) 2008-11-18

Similar Documents

Publication Publication Date Title
Schwarz et al. Trafficking from the bone marrow to the thymus: a prerequisite for thymopoiesis
Zhao et al. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells
Saleh et al. The impact of mesenchymal stem cells on differentiation of hematopoietic stem cells
Freud et al. Human natural killer cell development in secondary lymphoid tissues
Allan et al. TGF‐β affects development and differentiation of human natural killer cell subsets
Flores-Guzmán et al. Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine
ES2771248T3 (es) Diferenciación de células NK ex vivo de células hematopoyéticas CD34+
Rosmaraki et al. Identification of committed NK cell progenitors in adult murine bone marrow
de Pooter et al. In vitro generation of T lymphocytes from embryonic stem cell–derived prehematopoietic progenitors
JP2023002579A (ja) ヒト自然リンパ球前駆細胞：同定、特性評価、応用
Gastens et al. Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy
Christopherson Ii et al. CD26 inhibition on CD34+ or lineage− human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice
Girdlestone et al. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions
CN107922926B (zh) 培养和/或使造血干细胞分化为祖细胞的方法及其用途
Ambrosini et al. IL‐1β inhibits ILC3 while favoring NK‐cell maturation of umbilical cord blood CD34+ precursors
Philonenko et al. Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines
Almici et al. Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood
US8440460B2 (en) Methods for transdifferentiating cells
CA2562760A1 (en) A new method of expanding cord blood cells
JP5791506B2 (ja) 造血幹細胞または造血前駆細胞の分化を抑制するペプチド及びその用途
CN114107187A (zh) 一种牙髓间充质干细胞培养基及应用其的方法
Deutsch et al. Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte‐progenitor cells from cord blood
Chen et al. Sca‐1+ mesenchymal stromal cells inhibit splenic marginal zone B lymphocytes commitment through Caspase‐3
Huang et al. Hoxb5 reprogrammes murine multipotent blood progenitors into haematopoietic stem cell‐like cells
Huang et al. Flt3-Ligand–Mobilized Peripheral Blood, but Not Flt3-Ligand–Expanded Bone Marrow, Facilitating Cells Promote Establishment of Chimerism and Tolerance

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties